Predicting chemotherapy-induced thrombocytopenia in cancer patients with solid tumors or lymphoma

Abstract

We developed a predictive model for chemotherapy-induced thrombocytopenia based on readily available and easily assessable clinical and laboratory factors. This study may provide a valuable insight to guide optimized treatment of cancer patients. Further studies with larger sample size are warranted.